Try not to let market volatility bring you down. Instead, let dividend stocks make you happy. These high-yield dividend ...
Lastly, Pfizer is a solid dividend stock. It now offers a beefy 6.8% yield, and has increased its payouts by 53.6% in the ...
Buying stock in great companies when they are dealing with some short-term issue that creates stock price weakness can set ...
Pfizer’s (PFE) stock has fallen ill since the COVID-19 pandemic waned, and it is still experiencing some aftereffects. The ...
We recently published a list of 11 Best Innovative Stocks to Buy According to Analysts. In this article, we are going to take ...
Moderna, Baxter, and Pfizer are our top healthcare picks.
Pembrolizumab shows clinical promise as a treatment for mycosis fungoides and Sézary syndrome, achieving a response in nearly ...
Health care stocks have outperformed so far in 2025 despite uncertainty surrounding the new Donald Trump administration. Health care stocks can often be a solid defensive play in an uncertain economy.
Though 45% of patients said they could see the benefits of AI in health care, 44% said the idea of AI in health care settings scares them.
Patients in the pembrolizumab-olaparib arm had clinically meaningful improvements in PFS over patients in the control arm.
There has been another twist in the road for the ongoing legal battle between Seagen and Daiichi Sankyo over patent rights for antibody-drug conjugate (ADC) Enhertu. The US Patent and Trademark ...
The rumour that Merck & Co is preparing to make a sizeable offer to buy cancer specialist Seagen won't go away. The latest report - in the Wall Street Journal – says that "advanced talks" are ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results